Platform
Platform Capabilities
OmVitalis is an AI-powered multi-omics platform designed to integrate, analyze, and interpret biological data at scale. Backed by expert consulting and training, our platform transforms raw omics datasets into actionable biological intelligence.
Integrative Omics Consulting
The Challenge
Many institutions generate large-scale omics datasets but struggle to interpret results across layers. Integration-first approaches are needed to identify biologically meaningful signals with higher confidence and translational relevance.
Our Approach
OmVitalis specializes in integrative multi-omics interpretation, connecting signals across multiple biological layers to uncover mechanisms, biomarkers, and actionable scientific insight. We help research teams move beyond isolated analysis toward a unified biological narrative.
Who It's For
Multi-omics cohort studies, precision medicine research programs, aging and longevity biomarker discovery, infectious disease and immune response profiling, cancer multi-omics projects, and translational projects requiring integrated insight.
What We Deliver
Multi-omics integration strategy and analytical planning, cross-omics correlation and feature prioritization, pathway-level and systems biology interpretation, biomarker discovery and multi-layer validation frameworks, scientific narrative development and mechanistic insight, and decision-ready reporting.
Metabolomics & Lipidomics Interpretation
The Challenge
Metabolomics is one of the most biologically interpretable omics layers, but also one of the most complex to interpret correctly. High-confidence analysis aligned with biochemical pathways and translational relevance is essential.
Our Approach
OmVitalis provides advanced metabolomics and lipidomics interpretation, helping teams uncover metabolic pathways, biomarker signatures, and mechanistic insights relevant to disease biology, longevity, and precision health.
Who It's For
Longevity and aging metabolism profiling, cardiometabolic and inflammatory disease studies, cancer metabolism and metabolic reprogramming, infectious disease metabolic responses, and drug response and intervention studies.
What We Deliver
Data QC, normalization, and metabolite annotation support, differential abundance analysis and metabolite prioritization, pathway enrichment and biochemical interpretation, lipid class profiling and lipidomic signature discovery, metabolic network interpretation and visualization, and biomarker discovery and validation strategy support.
Genomics, Transcriptomics & Epigenetics
The Challenge
Genomics and transcriptomics provide powerful insight into disease susceptibility, gene regulation, and functional biology. Yet extracting interpretable mechanisms and prioritizing actionable targets from complex datasets requires specialized expertise.
Our Approach
OmVitalis supports projects requiring genomic interpretation, transcriptomic profiling, epigenetic insight, and regulatory network analysis. We deliver analytical rigor and biologically meaningful interpretation aligned with research and translational goals.
Who It's For
Precision medicine research programs, functional genomics and immune genomics studies, population genomics and cohort research, disease susceptibility and response modeling, and translational target discovery projects.
What We Deliver
Variant annotation and prioritization strategies, differential gene expression analysis, pathway enrichment and gene set interpretation, regulatory network and gene interaction mapping, epigenetic interpretation frameworks, and integrated omics interpretation with biological narrative reporting.
Single-Cell Transcriptomics & Immune Profiling
The Challenge
Single-cell datasets require specialized computational expertise, careful QC, and rigorous biological interpretation. Cellular resolution enables high-impact discovery that bulk sequencing cannot achieve.
Our Approach
OmVitalis provides advanced single-cell transcriptomics analytics to reveal cellular heterogeneity, immune signatures, and mechanistic pathways that are not visible in bulk sequencing approaches.
Who It's For
Immune response profiling, infection and inflammation biology, tumor microenvironment studies, aging immune signatures, and precision medicine and cohort stratification.
What We Deliver
scRNA-seq preprocessing, QC, and clustering, cell-type annotation and marker gene profiling, differential expression across conditions and cell types, immune landscape and pathway interpretation, trajectory analysis and cellular state discovery, integration with bulk transcriptomics or other omics layers, and publication-ready figures and cell-state reporting.
Bioinformatics & AI Analytics
The Challenge
The scale and dimensionality of omics data demand robust computational workflows. Reproducibility, scientific rigor, and interpretability must be maintained throughout the analytical pipeline.
Our Approach
OmVitalis delivers robust computational workflows for omics research, combining reproducible bioinformatics pipelines with AI-assisted analytics to accelerate discovery and strengthen interpretation.
Who It's For
Research groups requiring end-to-end analytics, from raw data preprocessing to integrated modeling and reporting, with emphasis on reproducibility and interpretability.
What We Deliver
Data preprocessing, normalization, and QC, differential abundance/expression analysis, statistical modeling and multivariate analytics, machine learning for classification and prediction, feature selection and biomarker prioritization, multi-omics integration frameworks, network-based and pathway-driven interpretation, and AI-assisted discovery and decision-support modeling.
R&D Strategy & Scientific Advisory
The Challenge
Strong datasets require strong strategy. Organizations must align study design, analytics, and biological interpretation with real-world goals such as publication, product development, grant funding, and translational research impact.
Our Approach
OmVitalis supports research institutions and biotech teams with strategic scientific advisory, helping them design stronger studies, build scalable data strategies, and develop high-impact proposals and R&D roadmaps.
Who It's For
Universities building omics research programs, biotech startups defining R&D pipelines, healthcare innovation programs and research units, government-funded innovation initiatives, and longevity and precision health programs.
What We Deliver
Study design optimization and omics experimental planning, data strategy and infrastructure recommendations, scientific advisory for translational R&D pipelines, grant and proposal development support, scientific writing and publication strategy guidance, and stakeholder-ready reports and scientific presentations.